# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001213900-23-014008
Filing Date
2023-02-23
Accepted
2023-02-23 16:52:38
Documents
35
Period of Report
2023-02-23
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | CURRENT REPORT | ea174171-8k_nektartherap.htm iXBRL | 8-K | 26387
2 | PRESENTATION TITLED "PHASE 2 ISLAND STUDY OF REZPEG IN SLE" | ea174171ex99-1_nektartherap.htm | EX-99.1 | 29254
3 | PRESS RELEASE TITLED "NEKTAR THERAPEUTICS ANNOUNCES PHASE 2 TOPLINE DATA FOR REZ | ea174171ex99-2_nektartherap.htm | EX-99.2 | 28369
4 | GRAPHIC | ex99-1_001.jpg | GRAPHIC | 111114
5 | GRAPHIC | ex99-1_002.jpg | GRAPHIC | 186510
6 | GRAPHIC | ex99-1_003.jpg | GRAPHIC | 233594
7 | GRAPHIC | ex99-1_004.jpg | GRAPHIC | 215521
8 | GRAPHIC | ex99-1_005.jpg | GRAPHIC | 292939
9 | GRAPHIC | ex99-1_006.jpg | GRAPHIC | 229743
10 | GRAPHIC | ex99-1_007.jpg | GRAPHIC | 184621
11 | GRAPHIC | ex99-1_008.jpg | GRAPHIC | 155965
12 | GRAPHIC | ex99-1_009.jpg | GRAPHIC | 143529
13 | GRAPHIC | ex99-1_010.jpg | GRAPHIC | 169617
14 | GRAPHIC | ex99-1_011.jpg | GRAPHIC | 164588
15 | GRAPHIC | ex99-1_012.jpg | GRAPHIC | 226426
16 | GRAPHIC | ex99-1_013.jpg | GRAPHIC | 180254
17 | GRAPHIC | ex99-1_014.jpg | GRAPHIC | 121320
18 | GRAPHIC | ex99-1_015.jpg | GRAPHIC | 130667
19 | GRAPHIC | ex99-1_016.jpg | GRAPHIC | 118029
20 | GRAPHIC | ex99-1_017.jpg | GRAPHIC | 226534
21 | GRAPHIC | ex99-1_018.jpg | GRAPHIC | 122163
22 | GRAPHIC | ex99-1_019.jpg | GRAPHIC | 144026
23 | GRAPHIC | ex99-1_020.jpg | GRAPHIC | 87869
24 | GRAPHIC | ex99-2_001.jpg | GRAPHIC | 6164
| Complete submission text file | 0001213900-23-014008.txt |  | 5024899

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
25 | XBRL SCHEMA FILE | nktr-20230223.xsd | EX-101.SCH | 3221
26 | XBRL LABEL FILE | nktr-20230223_lab.xml | EX-101.LAB | 34240
27 | XBRL PRESENTATION FILE | nktr-20230223_pre.xml | EX-101.PRE | 22355
29 | EXTRACTED XBRL INSTANCE DOCUMENT | ea174171-8k_nektartherap_htm.xml | XML | 3489

Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24006 | Film No.: 23660530
SIC: 2834 Pharmaceutical Preparations